Florbetaben-18F is a diagnostic radiopharmaceutical agent acting as a positron emission tomography (PET) tracer designed for the non-invasive imaging of cerebral amyloid-beta plaques associated with Alzheimer's… Read more
Florbetaben-18F is a diagnostic radiopharmaceutical agent acting as a positron emission tomography (PET) tracer designed for the non-invasive imaging of cerebral amyloid-beta plaques associated with Alzheimer's disease and other neurodegenerative conditions. Laboratories utilize these high-quality reference standards and related compounds to support rigorous quality control and method validation protocols necessary for clinical radiopharmacy. The category includes the parent radiotracer alongside critical impurity standards, such as N-nitroso Florbetaben-18F, which are essential for impurity profiling during routine analysis. These compounds allow researchers and quality assurance specialists to accurately assess radiolabeling integrity, verify compound stability, and ensure the precision of PET imaging diagnostics. By providing consistent analytical references, these materials facilitate compliance with pharmaceutical standards for the safe and accurate detection of amyloid deposition in patient populations.